CC
MYGN icon

Cipher Capital’s Myriad Genetics MYGN Stock Holding History

Cipher Capital’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$375K Buy
17,595
+1,069
+6% +$23K 0.17% 217
2023
Q4 		$316K Buy
+16,526
New +$286K 0.1% 317

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cipher Capital's MYGN Position: Q1 2024 in Review

Cipher Capital increased its Myriad Genetics (MYGN) stake by 6.5% in Q1 2024, buying an estimated $23K and bringing the position to 17,595 shares worth $375K. The position accounts for 0.17% of the portfolio, ranked #217.

Cipher Capital first reported a position in MYGN in Q4 2023 and has held it in 2 quarters since. 186 funds tracked by Wall St. Rank hold MYGN as of Q1 2024.

  • Cipher Capital held 17,595 shares of Myriad Genetics worth $375K as of Q1 2024.
  • Cipher Capital bought 1,069 Myriad Genetics shares in Q1 2024, an estimated $23K.
  • Myriad Genetics made up 0.17% of Cipher Capital's portfolio in Q1 2024, its #217 holding.
  • Cipher Capital first reported a position in Myriad Genetics in Q4 2023 and has held it in 2 quarters since.
  • 186 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2024.

Based on Cipher Capital's 13F filing for Q1 2024, filed 15 May 2024.